- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03067506
Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology
A Single Center Pilot Study to Evaluate Real Time Passive and Active High-Frequency Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology
Přehled studie
Detailní popis
The novel method being tested in this study for assessing mood and cognition in participants with MDD was wearable technology. This study looked at the correlation of mood and cognition outcomes on wearable technology with traditional objective neuropsychological cognitive function tests and self-reported mood outcomes.
The study enrolled approximately 30 patients. Participants were provided with a watch on which brief cognitive and mood tests were evaluated daily up to 6 weeks.
All participants prompted to complete cognitive and mood assessments on 3 occasions across the day. Two occasions (morning and afternoon) comprised assessment of cognition, and the final assessment in the evening constituted a review of the day focusing on self-reported depressed mood.
This single-center trial was conducted in United Kingdom. The overall time to participate in this study was 6 weeks. Participants took part up to 5 study visits (1 in-person on-site visit, 3 web-based and 1 at home visit) assessing performance on traditional objective neuropsychological cognitive function tests and self-reported measures of depression symptom severity and social function.
Typ studie
Zápis (Aktuální)
Kontakty a umístění
Studijní místa
-
-
-
London, Spojené království
- Takeda Investigative Site
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Has MDD as the primary psychiatric diagnosis.
- Has been treated previously with at least 1 antidepressant (monotherapy).
- Has scores on Participant Health Questionnaire-9 items (PHQ-9) ≥5 and PHQ-9 ≤15 at Screening
Exclusion Criteria:
- Has a significant risk of suicide according to the investigator's clinical judgment or has made an actual suicide attempt in the previous 6 months prior to Screening.
- Has a history of only responding to either combination or augmentation therapy in the current episode and has had been treated for more than a year without any period of remission.
Has 1 or more of the following:
- Current or history of: manic or hypomanic episode, schizophrenia or any other psychotic disorder, including schizoaffective disorder, major depression with psychotic features, bipolar depression with psychotic features, obsessive compulsive disorder, mental retardation, organic mental disorders, or mental disorders due to a general medical condition as defined in Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).
- Current diagnosis or history of alcohol or other substance abuse or dependence (excluding nicotine or caffeine).
- Neurodegenerative disorder (Alzheimer disease, Parkinson disease, multiple sclerosis, Huntington disease, etc).
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: Kohorta
- Časové perspektivy: Budoucí
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
---|---|
Participants With Major Depressive Disorder (MDD)
Participants with MDD were provided with an Apple watch on which brief cognitive and mood tests were evaluated daily up to 6 weeks.
|
Žádný zásah
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
Percentage of Days on Which Daily N-back Sessions Were Completed
Časové okno: Baseline up to Week 6
|
The cognitive assessment n-back test was completed on the wearable technology (Apple watch) on 3 occasions across the day in the morning, afternoon and evening.
|
Baseline up to Week 6
|
Percentage of Days on Which Daily Mood Assessment Tests Were Completed
Časové okno: Baseline up to Week 6
|
The Daily Mood assessments were completed on the wearable technology (Apple watch) once per day in the afternoon or evening.
|
Baseline up to Week 6
|
Correlation Coefficient Between Measures of Cognition (N-back Scores) and Performance on the Cambridge Neuropsychological Test Automated Battery (CANTAB) Tests: Spatial Working Memory Between Errors (SWMBE) and Spatial Working Memory Strategy (SWMS)
Časové okno: Baseline up to Week 6
|
The n-back was used to assess cognition 3 times a day. Participants responded by touching the watch face when a symbol matched the one presented 2-back. Average daily n-back score (d-prime) was calculated. CANTAB tests consists of a battery of neuropsychological tests. Spatial Working Memory (SWM) assessed retention of spatial data, ability to manipulate remembered items and strategize. Participant was asked to find tokens in on-screen boxes and move them. SWMBE=cumulative number of times participant went back to box that a token was previously removed per each successful study. Lower score was better. SWMS=number of unique boxes participant searched in two 6 and 8 box trials. Total of 4 trial scores ranged from 4-28. Lower score indicated better performance. Pearson's correlation coefficient measured linear correlation between n-back scores from Apple Watch and CANTAB tests, provided as a value +1=positive correlation to -1=negative correlation. 0=no correlation. |
Baseline up to Week 6
|
Correlation Coefficient Between Measures of Cognition (N-back Scores) and Performance on the CANTAB Test: Rapid Visual Information Processing (RVP)
Časové okno: Baseline up to Week 6
|
The n-back was used to assess cognition 3 times a day. Participants responded by touching the watch face when a symbol matched the one presented 2-back. Average daily n-back score (d-prime) was calculated. CANTAB tests consists of a battery of neuropsychological tests. RVP measures sustained attention. A white box appears in the center of the computer screen, inside which digits, from 2 to 9, appear in a pseudo-random order, at the rate of 100 digits per minute. Participants are requested to detect target sequences of digits. RVPA=measure of sensitivity to the target, regardless of response tendency (expected range is 0.00 to 1.00). Speed of Processing (RVPMDL)=The mean response latency during assessment sequence blocks where the participant responded correctly. Pearson's correlation coefficient measured linear correlation between n-back scores from Apple Watch and CANTAB tests, provided a value +1=positive correlation to -1=negative correlation. 0=no correlation. |
Baseline up to Week 6
|
Spolupracovníci a vyšetřovatelé
Sponzor
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- MDD-5003
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Velká depresivní porucha
-
Yonsei UniversityDokončeno
-
Technical University of MunichDokončenoDuodenální papila, majorNěmecko
-
National Science Council, TaiwanDokončenoSvalová síla | Povrchové EMG | Pectoralis Major | Měření sílyTchaj-wan
-
Dr Gerard O'ReillyAll India Institute of Medical Sciences, New Delhi; Monash University; The Alfred a další spolupracovníciDokončenoSchůzky ke zlepšení kvality strukturovaného traumatu ve čtyřech traumatických centrech v Indii (TQI)Velké trauma | Zranění majorIndie
-
Eindhoven University of TechnologyClinical Trial Center Maastricht B.V.Nábor
-
Shanghai Mental Health CenterZatím nenabíráme
-
Johns Hopkins Bloomberg School of Public HealthPatient-Centered Outcomes Research Institute; National Institute of Mental... a další spolupracovníciAktivní, ne náborDepresivní porucha, majorSpojené státy
-
ElMindA LtdNeznámýDepresivní porucha, majorIzrael, Švýcarsko
-
University of California, BerkeleyVanderbilt UniversityDokončenoDepresivní porucha, majorSpojené státy
-
University of Erlangen-Nürnberg Medical SchoolDokončenoDepresivní porucha, majorNěmecko
Klinické studie na Žádný zásah
-
CSA Medical, Inc.UkončenoBarrettův jícen | Dysplazie nízkého stupně | Dysplazie vysokého stupněSpojené státy
-
University of PittsburghNational Institute of Mental Health (NIMH)NáborSebevražda | ÚmrtíSpojené státy
-
Otsuka Pharmaceutical Factory, Inc.CelerionDokončeno
-
Oregon Research InstituteDokončenoZneužívání návykových látekSpojené státy
-
Sarah BlaylockVA Office of Research and DevelopmentDokončenoPodzim | Nízké viděníSpojené státy
-
VA Office of Research and DevelopmentDokončenoRakovina tlustého střevaSpojené státy
-
Catharina Ziekenhuis EindhovenDokončeno
-
Idaho State UniversityZatím nenabírámeExperimentální videohry | Hodnocení chování